Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer

Table 7 Stratification analysis of oncological and survival outcomes between high-ratio and low-ratio grades in both emergency surgery and bridge to surgery groups

Characteristic	3-year OS		3-year DFS
	HR (95%CI)	P-value	HR (95%CI)	P-value
ES (dNLR < 1.57)	Reference	-	Reference	-
BTS (dNLR < 1.57)	0.51 (0.18-1.39)	0.185	0.42 (0.13-1.34)	0.144
ES (dNLR ≥ 1.57)	Reference	-	Reference	-
BTS (dNLR ≥ 1.57)	1.87 (0.79-4.43)	0.155	1.79 (0.77-4.20)	0.178
ES (LMR < 1.67)	Reference	-	Reference	-
BTS (LMR < 1.67)	4.34 (1.27-14.82)	0.019	2.72 (0.97-7.65)	0.058
ES (LMR ≥ 1.67)	Reference	-	Reference	-
BTS (LMR ≥ 1.67)	0.40 (0.18-0.92)	0.031	0.42 (0.17-1.07)	0.068

SEMS: Self-expanding metal stents; BTS: Bridge to surgery; dNLR: Derived neutrophil-to-lymphocyte ratio; OS: Overall survival; DFS: Disease-free survival; LMR: Lymphocyte-to-monocyte ratio. P < 0.05 was considered statistically significant.